During our study, we were able to identify close to 500 players that are engaged in offering pharmaceutical contract manufacturing services. It is worth mentioning, most of the players (174) engaged in this domain offer contract manufacturing services for FDF / fill-finish operations, followed by those offering services for both API and FDF / fill-finish development (144).
To Request for Sample report – https://www.rootsanalysis.com/reports/view_document/pharmaceutical-contract-manufacturing-market/191.html
As can be observed in the figure, the pharmaceutical market is currently dominated by the presence of large and very large players (47%), followed by mid-sized firms (42%) and small companies (11%). Notable examples of well-established players engaged in this domain include (large and very large companies, in alphabetical order) Alembic Pharmaceutical, Angelini Pharma, Divi’s Laboratories, Fresenius Kabi and Lubrizol Life Sciences.
It is worth highlighting that, most of the pharmaceutical CMOs are based in Asia Pacific (50%), followed by those headquartered in Europe (26%) and North America (21%). Further, within Europe, most of the CMOs are based in Italy (19), followed by those headquartered in Germany (18), Spain (16), the UK (13), Switzerland (13) and France (12).
To Request for customize report – https://www.rootsanalysis.com/reports/pharmaceutical-contract-manufacturing-market-2nd-edition-2018-2028/request-customization.html
In terms of the type of service(s) offered, most of the companies engaged in this domain offer services for method development, and packaging and labelling (62%, each), followed by those offering scale-up services (58%) and formulation development services (52%). Notable examples of players offering all types of services include (in alphabetical order) AMRI, Altasciences, Almac, Catalent, MiPharm, Patheon and Recipharm
To request for report, click under – https://www.rootsanalysis.com/reports/191/request-sample.html
Other Recent Offerings
1. Brain Concussion Market, 2021-2031
2. Hunter Syndrome: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031
3. Pediatric Brain Tumors: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031
4. Neurotrophic Keratitis: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031
5. Neuromyelitis Optica Spectrum Disorder (2nd Edition): Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at firstname.lastname@example.org
+1 (415) 800 3415